IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer | IDYA Stock NewsStockTitan·Aug 18 at 09:00 PMRHHBY+1.48%IDYA+1.43%
AI Pipelines, Cancer Drugs, and Gold: The Schizophrenic Market of 2026Global Report·Aug 18 at 04:43 AMNEXOY+1.57%MRLN-2.67%
LifeSci Capital Sticks to Its Buy Rating for IDEAYA Biosciences (IDYA)Tip Ranks·Aug 8 at 09:35 AMIDYA+1.43%
IDEAYA Biosciences (NASDAQ:IDYA) Given New $59.00 Price Target at Truist FinancialMarket Beat·Aug 5 at 01:24 PMIDYA+1.43%
IDEAYA Q2 2026 earnings: Darovasertib NDA advances with $1.24 billion in cashTradingKey·Aug 5 at 01:24 AMIDYA+1.43%
Ideaya Biosciences | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 8.857 MEarnings Watch·Aug 4 at 05:07 AMIDYA+1.43%
IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update | IDYA Stock NewsStockTitan·Aug 3 at 09:00 PMIDYA+1.43%RHHBY+1.48%
IDEAYA Biosciences grants 260,200 inducement stock options at $36.4 per sharePUBT·Jul 31 at 05:00 AMIDYA+1.43%
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | IDYA Stock NewsStockTitan·Jul 30 at 09:00 PMIDYA+1.43%
